Keywords: Takeover deals, Differences, Europe, USA, Sanofi-Aventis, Genzyme, Evershed, Datamonitor

Agreement on Sanofi-Aventis/Genzyme deal prompts lawyer comment on Europe/USA differences on takeovers

Article | 17 February 2011

Print This

Following yesterday’s announcement that the French pharmaceutical group Sanofi-Aventis (Euronext: SAN) had finally managed to put together an ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in